Hypermethylated LTR retrotransposon exhibits enhancer activity

Epigenetics

Volumn 12, Issue 3, 2017, Pages 226-237

  Hu, Tianxiang ^a   Zhu, Xingguo ^a   Pi, Wenhu ^a   Yu, Miao ^a   Shi, Huidong ^a   Tuan, Dorothy ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

ChIP EMSA; CRISPR cas9; LTR enhancer; LTR hypermethylation; retrotransposon; transcription factor binding to methylated DNA

Indexed keywords

HEMOGLOBIN BETA CHAIN; HEMOGLOBIN GAMMA CHAIN; NUCLEAR FACTOR Y; RESTRICTION ENDONUCLEASE; TRANSCRIPTION FACTOR GATA 1; GATA1 PROTEIN, HUMAN; RETROPOSON; TRANSCRIPTION FACTOR;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA METHYLATION; ENHANCER REGION; GEL MOBILITY SHIFT ASSAY; GENE LOCUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; OVERLAPPING GENE; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; RETROPOSON; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SANGER SEQUENCING; WHOLE GENOME SEQUENCING; ANTIBODY SPECIFICITY; EPIGENETICS; GENETIC TRANSCRIPTION; GENETICS; HUMAN GENOME; PROMOTER REGION;

DNA METHYLATION; ENHANCER ELEMENTS, GENETIC; EPIGENOMICS; GATA1 TRANSCRIPTION FACTOR; GENOME, HUMAN; HUMANS; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; RETROELEMENTS; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 85014512752     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.1080/15592294.2017.1289300     Document Type: Article

References (72)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921; PMID:11237011; http://dx.doi.org/10.1038/35057062
2. Henikoff S, Greene EA, Pietrokovski S, Bork P, Attwood TK, Hood L. Gene families:the taxonomy of protein paralogs and chimeras. Science 1997; 278:609-14; PMID:9381171; http://dx.doi.org/10.1126/science.278.5338.609
3. Wilkison D, Mager D, Leong J. In “The retroviridae” Levy J, Ed., (Plenum Press) 1997; 3:465-535 (1994)
4. Temin HM. Structure, variation and synthesis of retrovirus long terminal repeat. Cell 1981; 27:1-3; PMID:7326747; http://dx.doi.org/10.1016/0092-8674(81)90353-6
5. Smit AF. The origin of interspersed repeats in the human genome. Curr Opin Genet Dev 1996; 6:743-8; PMID:8994846; http://dx.doi.org/10.1016/S0959-437X(96)80030-X
6. Jurka J, Kapitonov VV, Pavlicek A, Klonowski P, Kohany O, Walichiewicz J. Repbase Update, a database of eukaryotic repetitive elements. Cytogenet Genome Res 2005; 110:462-7; PMID:16093699; http://dx.doi.org/10.1159/000084979
7. Bao W, Kojima KK, Kohany O. Repbase Update, a database of repetitive elements in eukaryotic genomes. Mob DNA 2015; 6:11-2; PMID:26045719; http://dx.doi.org/10.1186/s13100-015-0041-9
8. Hughes J, Coffin J. Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat Genet 2001; 29:487-9; PMID:11704760; http://dx.doi.org/10.1038/ng775
9. Bourc'his D, Bestor TH. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 2004; 431:96-9; PMID:15318244; http://dx.doi.org/10.1038/nature02886
10. Maksakova IA, Romanish MT, Gagnier L, Dunn CA, van de Lagemaat LN, Mager DL. Retroviral elements and their hosts:insertional mutagenesis in the mouse germ line. PLoS Genet, 2006; 2:e2; PMID:16440055; http://dx.doi.org/10.1371/journal.pgen.0020002
11. Howard G, Eiges R, Gauder F, Jenisch R, Eden A. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogen 2007; 27:404-8; http://dx.doi.org/10.1038/sj.onc.1210631
12. Goodier J, Kazazian H. Retrotransposons revisited:The restraint and rehabilitation of parasites. Cell 2008; 135:23-35; PMID:18854152; http://dx.doi.org/10.1016/j.cell.2008.09.022
13. Slotkin K, Martienssen R. Transposable elements and the epigenetic regulation of the genome. Nat Genetics 2007; 8:272-85; PMID:17363976; http://dx.doi.org/10.1038/nrg2072
14. Aravin A, Sachidanandam R, Bourc'his D, Schaefer C, Pezic D, Toth KF, Bestor T, Hannon GJ. A piRNA pathway primed by individual transposons is linked to De Novo DNA methylation in mice. Mol Cell 2008; 31:785-99; PMID:18922463; http://dx.doi.org/10.1016/j.molcel.2008.09.003
15. Kuramochi- Miyagawa S, Watanabe T, Gotoh K, Totoki Y, Toyoda A, Ikawa M, Asada N, Kojima K, Yamaguchi Y, Ijiri TW, et al. DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes. Genes Dev 2008; 22:908-17; PMID:18381894; http://dx.doi.org/10.1101/gad.1640708
16. Malone C, Hannon G. Small RNAs as guardians of the genome. Cel 2009; 136:656-68; http://dx.doi.org/10.1016/j.cell.2009.01.045
17. Shalgi R, Pipel Y, Oren M. Repression of transposable elements—a microRNA anti-cancer defense mechanism? Trends Genetics 2010; 26:253-9; PMID:20417576; http://dx.doi.org/10.1016/j.tig.2010.03.006
18. Stavenhagen JB, Robins DM. An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. Cell 1988; 55:247-54; PMID:3167981; http://dx.doi.org/10.1016/0092-8674(88)90047-5
19. Ting C, Rosenberg M, Snow C, Samuelson L, Meisler M. Endogenous retroviral seuences are required for tissue-specific expression of a human salivary amylase gene. Genes Dev 1992; 6:1457-65; PMID:1379564; http://dx.doi.org/10.1101/gad.6.8.1457
20. Feuchter AE, Freeman DJ, Mager DL. Splicing of a human endogenous retrovirus to phospholipase A2 related gene. Nucleic Acids Res 1993; 21:135-43; PMID:8382789; http://dx.doi.org/10.1093/nar/21.1.135
21. Schulte AM, Lai S, Kurtz A, Czubayko F, Riegel AT, Wellstein A. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc Natl Acad Sci USA 1996; 93:14759-64; PMID:8962128; http://dx.doi.org/10.1073/pnas.93.25.14759
22. Beyer U, Moll-Rocek J, Moll UM, Dobbelstein M. Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes. Proc Natl Acad Sci U S A 2011; 108:3624-9; PMID:21300884; http://dx.doi.org/10.1073/pnas.1016201108
23. Yu X, Zhu X, Pi W, Ling J, Ko L, Takeda Y, Tuan D. The LTR of ERV-9 human endogenous retrovirus binds to NF-Y in the assembly of an active LTR enhancer complex NF-Y/MZF1/GATA-2. J Biol Chem 2005; 280:35184-94; PMID:16105833; http://dx.doi.org/10.1074/jbc.M508138200
24. Wang T, Zeng J, Lowe CB, Sellers RG, Salama SR, Yang M, Burgess SM, Brachmann RK, Haussler D. Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53. Proc Natl Acad Sci U S A 2007; 104:18613-8; PMID:18003932; http://dx.doi.org/10.1073/pnas.0703637104
25. Kunarso G, Chia NY, Jeyakani J, Hwang C, Lu X, Chan YS, Ng HH, Bourque G. Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat Genet 2010; 42:631-4; PMID:20526341; http://dx.doi.org/10.1038/ng.600
26. Wang J, Xie G, Singh M, Ghanbarian AT, Rasko T, Szvetnik A, Cai H, Besser D, Prigione A, Fuchs NV, et al. Primate-specific endogenous retrovirus-driven transcription defines naive-like stem cells. Nature 2014; 516:405-9; PMID:25317556; http://dx.doi.org/10.1038/nature13804
27. Ohnuki M, Tanabe K, Sutou K, Teramoto I, Sawamura Y, Narita M, Nakamura M, Tokunaga Y, Watanabe A, Yamanaka S, et al. Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential. Proc Natl Acad Sci U S A 2014; 111:12426-31; PMID:25097266; http://dx.doi.org/10.1073/pnas.1413299111
28. Sela N, Mersch B, Gal-Mark N, Lev-Maor G, Hotz A, Ast G. Comparative analysis of transposed element insertion within human and mouse genomes reveals Alu's role in shaping the human transcriptome. Genome Biol 2007; 8:R127; http://dx.doi.org/10.1186/gb-2007-8-6-r127
29. Faulkner GJ, Kimura Y, Daub CO, Wani S, Plessy C, Irvine KM, Schroder K, Cloonan N, Steptoe AL, Lassmann T, et al. The regulated retrotransposon transcriptome of mammalian cells. Nat Genet 2009; 41:563-71; PMID:19377475; http://dx.doi.org/10.1038/ng.368
30. Fort A, Hashimoto K, Yamada D, Salimullah M, Keya CA, Saxena A, Bonetti A, Voineagu I, Bertin N, Kratz A, et al. Deep transcriptome profiling of mammalian stem cells supports a regulatory role for retrotransposons in pluripotency maintenance. Nat Genet 2014; 46:558-66; PMID:24777452; http://dx.doi.org/10.1038/ng.2965
31. Goke J, Lu X, Chan YS, Ng HH, Ly LH, Sachs F, Szczerbinska I. Dynamic transcription of distinct classes of endogenous retroviral elements marks specific populations of early human embryonic cells. Cell Stem Cell 2015; 16:135-41; PMID:25658370; http://dx.doi.org/10.1016/j.stem.2015.01.005
32. Kelley D, Rinn J. Transposable elements reveal a stem cell-specific class of long noncoding RNAs. Genome Biol 2012; 13:R107; PMID:23181609; http://dx.doi.org/10.1186/gb-2012-13-11-r107
33. Xie M, Hong C, Zhang B, Lowdon R, Xing X, Li D, Zhou X, Lee H, Cecile L, Maire C, Ligon K, et al. DNA hypomethylation within specific transposable element families associates with tissue-specific enhancer landscape. Nat Genetics 2013; 45:836-41; PMID:23708189; http://dx.doi.org/10.1038/ng.2649
34. Ling J, Pi W, Bollag R, Zeng S, Keskintepe M, Saliman H, Krantz S, Whitney B, Tuan D. The solitary long terminal repeats of ERV-9 endogenous retrovirus are conserved during primate evolution and possess enhancer activities in embryonic and hematopoietic cells. J Virol 2002; 76:2410-23; PMID:11836419; http://dx.doi.org/10.1128/jvi.76.5.2410-2423.2002
35. Pi W, Yang Z, Wang J, Ruan L, Yu X, Ling J, Krantz S, Isales C, Conway SJ, Lin S, et al. The LTR enhancer of ERV-9 human endogenous retrovirus is active in oocytes and progenitor cells in transgenic zebrafish and humans. Proc Natl Acad Sci U S A 2004; 101:805-10; PMID:14718667; http://dx.doi.org/10.1073/pnas.0307698100
36. Ling J, Pi W, Yu X, Bengra C, Long Q, Jin H, Seyfang A, Tuan D. The ERV-9 LTR enhancer is not blocked by the HS5 insulator and synthesizes through the HS5 site non-coding, long RNAs that regulate LTR enhancer function. Nucleic Acids Res 2003; 31:4582-96; PMID:12888519; http://dx.doi.org/10.1093/nar/gkg646
37. Pi W, Zhu X, Wu M, Wang Y, Eroglu A, Ling J, Tuan D. Long-range function of an intergenic retrotransposon. Proc Natl Acad Sci 2010; 107:12992-7; PMID:20615953; http://dx.doi.org/10.1073/pnas.1004139107
38. Fordis CM, Anagnou NP, Dean A, Nienhuis AW, Schechter AN. A beta-globin gene, inactive in the K562 leukemic cell, functions normally in a heterologous expression system. Proc Natl Acad Sci 1984; 81:4485-9; PMID:6205398; http://dx.doi.org/10.1073/pnas.81.14.4485
39. Zhu X, Wang Y, Pi W, Liu H, Wickrema A, Tuan D. NF-Y recruits both transcription activator and repressor to modulate tissue- and developmental stage-specific expression of human gamma-globin gene. PLoS One 2012; 7:e47175; PMID:23071749; http://dx.doi.org/10.1371/journal.pone.0047175
40. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts:somatic differentiation in vitro. Nat Biotechnol 2013; 18:399-404
41. Shull AY, Noonepalle SK, Lee EJ, Choi JH, Shi H. Sequencing the cancer methylome. Methods Mol Biol 2015; 1238:627-51; PMID:25421684
42. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013; 8:2281-308; PMID:24157548; http://dx.doi.org/10.1038/nprot.2013.143
43. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-guided human genome engineering via Cas9. Science 2013; 339:823-6; PMID:23287722; http://dx.doi.org/10.1126/science.1232033
44. Lin S, Staahl BT, Alla RK, Doudna JA. Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. Elife 2014; 3:e04766; PMID:25497837
45. Groudine M, Kohwi-Shigematsu T, Gelinz R, Stamatoyannopoulos G, Papayannopoulou T. Human fetal to adult hemoglobin switching:changes in chromatin structure of the b-globin gene locus. Proc Natl Acad Sci 1983; 80:7551-5; PMID:6200877; http://dx.doi.org/10.1073/pnas.80.24.7551
46. Tuan D, Solomon W, Li Q, London IM. The “β-Like-Globin” Gene domain in human erythroid. Cells Proc Natl Acad Sci 1985; 82:6384-8; PMID:3879975; http://dx.doi.org/10.1073/pnas.82.19.6384
47. Klose RJ, Bird AP. Genomic DNA methylation:the mark and its mediators. Trends Biochem Sci 2006; 31:89-97; PMID:16403636; http://dx.doi.org/10.1016/j.tibs.2005.12.008
48. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 2004; 32:4100-8; PMID:15302911; http://dx.doi.org/10.1093/nar/gkh739
49. Mellén M, Ayata P, Dewell S, Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 2012; 15:1417-30; http://dx.doi.org/10.1016/j.cell.2012.11.022
50. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008; 320:1224-9; PMID:18511691; http://dx.doi.org/10.1126/science.1153252
51. Rupon JW, Wang SZ, Gaensler K, Lloyd J, Ginder GD. Methyl binding domain protein 2 mediates gamma-globin gene silencing in adult human betaYAC transgenic mice. Proc Natl Acad Sci 2006; 103:6617-22; PMID:16608912; http://dx.doi.org/10.1073/pnas.0509322103
52. Rincón-Arano H, Guerrero G, Valdes-Quezada C, Recillas-Targa F. Chicken alpha-globin switching depends on autonomous silencing of the embryonic pi globin gene by epigenetics mechanisms. J Cell Biochem 2009; 108:675-87; PMID:19693775; http://dx.doi.org/10.1002/jcb.22304
53. Booth MJ, Ost TW, Beraldi D, Bell NM, Branco MR, Reik W, Balasubramanian S. Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine. Nat Protoc 2013; 8:1841-51; PMID:24008380; http://dx.doi.org/10.1038/nprot.2013.115
54. Dalle B, Rubin J, Alkan O, Sukonnik T, Pasceri P, Yao S, Pawliuk R, Leboulch P, Ellis J. eGFP reporter genes silence LCR β-globin transgene expression via CpG dinucleotides. Mol Therapy 2005; 11:591-9; PMID:15771961; http://dx.doi.org/10.1016/j.ymthe.2004.11.012
55. Klug M, Rehli M. Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics 2006; 1:127-30; PMID:17965610; http://dx.doi.org/10.4161/epi.1.3.3327
56. Hu T, Pi W, Zhu X, Yu M, Ha H, Shi H, Choi J, Tuan D. Long noncoding RNAs transcribed by ERV-9 LTR retrotransposon act in cis to modulate long-range LTR enhancer function. Nuc Acids Res 2017; E pub ahead of print; http://dx.doi.org/10.1093/nar/gkx055
57. Calo E, Wysocka J. Modification of enhancer chromatin:What, how and why? Mol Cell 2013; 49:825-37
58. Madzo J, Liu H, Rodriguez A, Vasanthakumar A, Sundaravel S, Caces B, Looney T, Zhang L, Lepore J, Macrae Y, et al. Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis. Cell Reports 2013; 6:231-44; PMID:24373966; http://dx.doi.org/10.1016/j.celrep.2013.11.044
59. Feldmann A, Ivanek R, Murr R, Gaidatzis D, Burger L, Schübeler D. Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. PLoS Genet 2013; 9:e1003994; PMID:24367273; http://dx.doi.org/10.1371/journal.pgen.1003994
60. Chen PY, Feng S, Joo JW, Jacobsen SE. Pellegrini MA comparative analysis of DNA methylation across human embryonic stem cell lines. Genome Biol 2011; 12:R62; PMID:21733148; http://dx.doi.org/10.1186/gb-2011-12-7-r62
61. Montavani R. The molecular biology of the CCAAT-binding factor NF-Y. Gene 1999; 239:15-27; PMID:10571030; http://dx.doi.org/10.1016/S0378-1119(99)00368-6
62. Höller M, Westin G, Jiricny J, Schaffner W. Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 1988; 2:1127-35; PMID:3056778; http://dx.doi.org/10.1101/gad.2.9.1127
63. Maureen A, Harrington P, Jones A, Imagawat M, Karin M. Cytosine methylation does not affect binding of transcription factor Spl. Proc Nati Acad Sci 1988; 85:2066-70; http://dx.doi.org/10.1073/pnas.85.7.2066
64. Stamatoyannopoulos G. Control of globin gene expression during development and erythroid differentiation. Exp Hematol 2005; 33:259-71; PMID:15730849; http://dx.doi.org/10.1016/j.exphem.2004.11.007
65. Zhu H, Wang G, Qian J. Transcription factors as readers and effectors of DNA methylation. Nat Rev Genet 2016; 17:551-65; PMID:27479905; http://dx.doi.org/10.1038/nrg.2016.83
66. Jones PA. Functions of DNA methylation:islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13:484-92; PMID:22641018; http://dx.doi.org/10.1038/nrg3230
67. Georgel P, Horowitz-Scherer R, Adkins N, Woodcock C, Wadw P, Hensen J. Chromatin Compaction by Human MeCP2. J Biol Chem 2003; 278:32181-8; PMID:12788925; http://dx.doi.org/10.1074/jbc.M305308200
68. Bell AC, West AG, Felsenfeld G. The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell 1999; 98:387-96; PMID:10458613; http://dx.doi.org/10.1016/S0092-8674(00)81967-4
69. West AG, Huang S, Gaszner M, Litt MD, Felsenfeld G. Recruitment of histone modifica-tions by USF proteins at a vertebrate barrier element. Mol Cell 2004; 16:453-63; PMID:15525517; http://dx.doi.org/10.1016/j.molcel.2004.10.005
70. Huang S, Li X, Yusufzai TM, Qiu Y, Felsenfeld G. USF1 recruits histone modification complexes and is critical for maintenance of a chromatin barrier. Mol Cell Biol 2007; 27:7991-8002; PMID:17846119; http://dx.doi.org/10.1128/MCB.01326-07
71. Smith ZD, Chan MM, Humm KC, Karnik R, Regev A, Eggan K, Meissner A. DNA methylation dynamics of the human preimplantation embryo. Nature 2014; 511:611-5; PMID:25079558; http://dx.doi.org/10.1038/nature13581
72. Friedli M, Turelli P, Kapopoulou A, Rauwel B, Castro-Díaz N, Rowe HM, Ecco G, Unzu C, Planet E, Lombardo A, Mangeat B, et al. Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency. Genome Res 2014; 24:1251-9; PMID:24879558; http://dx.doi.org/10.1101/gr.172809.114